| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Colony American Homes (tba) | Credit Suisse/ Morgan Stanley/ BofA Merrill Lynch | $100.00 | n.a. | |||
| Claire’s Inc. (CLRS) | TBA | $100.00 | n.a. | |||
| Cherry Hill Mortgage Investment (CHMI) | Barclays/ Morgan Stanley/ Citigroup/ UBS Investment Bank | $149.50 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| ADMA Biologics (tba) | Oppenheimer/ BMO Capital Markets | 2.10 | $13.50 | $15.50 | $30.45 | 1-Star |
| Withdrawn | ||||||
| Harvard Apparatus Regenerative Technology (HART) | Summer Street Research Partners | 1.70 | $10.00 | $12.00 | $18.70 | 1-Star |
| Language Line Services Holdings ( LLS ) | Morgan Stanley/ Credit Suisse/ BofA Merrill Lynch | $400.00 | 1-Star | |||
| New Terms | ||||||
| ADMA Biologics (ADMA) | Oppenheimer/ BMO Capital Markets | 3.05 | $8.00 | $9.00 | $25.93 | 1-Star |
| Alcobra Ltd. (ADHD) | Aegis Capital | 2.28 | $10.00 | $12.00 | $25.03 | 1-Star |
| Ambit Biosciences (AMBI) | Citigroup/ Leerink Swann | 4.65 | $13.00 | $15.00 | $65.03 | 1-Star |
| American Residential Properties (ARPI) | Morgan Stanley/ BofA Merrill Lynch/ FBR/ Jefferies | 13.70 | $21.00 | $23.00 | $301.41 | 1-Star |
| Capitol Acquisition (CLAQU) | Citigroup/ Deutsche Bank Securities | 15.00 | $10.00 | $10.00 | $150.00 | 1-Star |
| Emerge Energy Services LP (EMES) | Citigroup/ Wells Fargo Securities/ J.P. Morgan | 7.50 | $19.00 | $21.00 | $150.00 | 1-Star |
| First NBC Bank Holding (NBCB) | SANDLER O’NEILL + PARTNERS/ Keefe, Bruyette & Woods (A Stifel Company ) | 4.17 | $22.00 | $26.00 | $100.00 | 2-Star |
| Insys Therapeutics (INSY) | Wells Fargo Securities/ JMP Securities | 4.00 | $8.00 | $10.00 | $36.00 | 1-Star |
| PennyMac Financial Services (PFSI) | Citigroup/ BofA Merrill Lynch/ Credit Suisse/ Goldman, Sachs | 11.11 | $17.00 | $19.00 | $200.00 | 1-Star |
| RCS Capital (RCAP) | JMP Securities/ Ladenburg Thalmann | $86.25 | 1-Star | |||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of April 29, 2013 | Manager(s) | Offered | Raised | Price | 5/3/13 | Change |
| Insys Therapeutics (INSY) | Wells Fargo Securities/ JMP Securities | 4.00 | $32.00 | $8.00 | $9.70 | 21.25% |
| ING U.S. (VOYA) | Morgan Stanley/ Goldman, Sachs/ Citigroup/ BofA Merrill Lynch/ Credit Suisse/ Deutsche Bank Securities/ J.P. Morgan | 65.20 | $1,271.40 | $19.50 | $20.67 | 6.00% |
| GW Pharmaceuticals plc (GWPH) | Lazard Capital Markets/ Cowen and Company | 3.50 | $31.15 | $8.90 | $9.04 | 1.57% |
| QIWI plc (QIWI) | J.P. Morgan/ Credit Suisse | 12.50 | $212.50 | $17.00 | $17.08 | 0.47% |
| Harvest Capital Credit (HCAP) | Keefe, Bruyette & Woods (A Stifel Company )/ JMP Securities/ William Blair | 3.40 | $51.00 | $15.00 | $15.00 | 0.00% |
| Ellington Residential Mortgage REIT (EARN) | Credit Suisse/ Deutsche Bank Securities/ Citigroup/ UBS Investment Bank | 6.45 | $129.00 | $20.00 | $19.58 | -2.10% |
